Sun Pharma announced it started integrating Indian group Ranbaxy after completing its acquisition, so that the group became the owner of the biggest Romanian drug maker, Cluj-based Terapia.
The Cluj plant plays an extremely important role at the group as it secures it access to the European market. Sun also has production facilities in Hungary and Ireland, but these are smaller compared with the Cluj one.
Emerging markets come third in the ranking of regions that bring the biggest sales for Sun, after the US and India.
Brazil, Mexico, Russia and Romania are the biggest emerging markets where the Indian group wants to grow faster than the market.
Terapia exports to Russia, Ukraine, Western Europe and other states and the product posting the biggest deliveries abroad is Faringosept.
Romania is also a key market on the segment of OTC drugs, ranking among the top ten players, according to the group’s data.
Terapia is one of the 45 plants Sun Pharma operates worldwide.
(English version by Catalina Apostoiu)